Developing vaccines to fight antibiotic-resistant bacteria
Official title: Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
Funded at Eveliqure Biotechnologies, Gmbh · NIH-11193188 · Data updated 2026-11-12
This study is working on new vaccines to help fight infections caused by bacteria that don't respond to regular antibiotics, and it's designed for people who want to help improve treatments for serious infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Eveliqure Biotechnologies, Gmbh NIH-funded |
| Lab location | 1 site (Veinna, Austria) |
| Project start | September 1, 2020 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $198,329 |
| NIH project number | 75N93020C00048-P00011-9999-1 |
| Project ID | NIH-11193188 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would include individuals at high risk for infections caused by antibiotic-resistant bacteria, such as those with compromised immune systems or chronic health conditions.
✕Less likely to help
Patients who are not at risk for antibiotic-resistant infections or those who do not have any underlying health conditions may not benefit from this research.
What this research studies
This research focuses on creating and testing vaccine candidates aimed at combating antibiotic-resistant bacteria, particularly in response to outbreaks of infectious diseases. The approach involves formulating vaccine components, conducting stability tests, and performing immunogenicity and efficacy evaluations in animal models. The research also includes toxicology assessments and the preparation for clinical trials to ensure safety and effectiveness for future human use.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect against infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Other research has shown promise in developing vaccines against antibiotic-resistant bacteria, indicating that this approach has potential for success.
Where this research is happening
-
Eveliqure Biotechnologies, Gmbh
Veinna, Austria Active
Researchers
- Principal investigator: Malinowski, Frank — Eveliqure Biotechnologies, Gmbh
- Study coordinator: Malinowski, Frank
Related research
Other NIH-funded projects on the same topics.
-
Developing vaccines to fight antibiotic-resistant bacteria
This study is working on a new vaccine to help fight bacteria that don't respond to regular antibiotics, and it will eventually involve people to see how safe and effective the vaccine is.
-
Developing vaccines to fight antibiotic-resistant bacteria
This study is working on developing vaccines to help protect people from infections caused by bacteria that don't respond to regular antibiotics, and it's aimed at making sure these vaccines are safe and effective for future use in humans.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.